Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan Carefully In Writing Combo Product Designation Requests, Experts Say

This article was originally published in The Gray Sheet

Executive Summary

Companies need to carefully consider tactics for ensuring proper regulation of combination products, including looking at whether a manufacturer really needs a formal request for designation, say industry and legal experts.

Advertisement

Related Content

Combo Products Won't Get Special Review Pathway At US FDA Anytime Soon
Primary-Mode-Of-Action Rule For Combo Products Is Similar To Earlier Draft

Topics

Advertisement
UsernamePublicRestriction

Register

MT034565

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel